Goldman Sachs Group Inc Xencor Inc Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 716,392 shares of XNCR stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

716,392

Previous 726,734 1.42%

Holding current value

$10.7 Million

Previous $7.73 Million 27.19%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$7.52 - $11.26 $77,771 - $116,450	-10,342 Reduced 1.42%	716,392 $5.63 Million
Q1 2025 May 09, 2025	BUY	$10.64 - $24.13 $3.66 Million - $8.3 Million	344,088 Added 89.92%	726,734 $7.73 Million
Q4 2024 Feb 11, 2025	BUY	$19.43 - $26.84 $301,339 - $416,261	15,509 Added 4.22%	382,646 $8.79 Million
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $1.53 Million - $2.11 Million	-97,675 Reduced 21.01%	367,137 $7.38 Million
Q2 2024 Aug 13, 2024	BUY	$18.21 - $24.5 $2.3 Million - $3.09 Million	126,304 Added 37.31%	464,812 $8.8 Million
Q1 2024 May 15, 2024	SELL	$18.65 - $26.52 $1.85 Million - $2.64 Million	-99,392 Reduced 22.7%	338,508 $7.49 Million
Q4 2023 Feb 13, 2024	BUY	$16.53 - $21.42 $4.21 Million - $5.45 Million	254,537 Added 138.82%	437,900 $9.3 Million
Q3 2023 May 14, 2024	SELL	$20.08 - $25.39 $5.11 Million - $6.46 Million	-254,537 Reduced 58.13%	183,363 $3.69 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $7.71 Million - $9.75 Million	-383,982 Reduced 67.68%	183,363 $3.69 Million
Q2 2023 May 14, 2024	SELL	$24.77 - $29.9 $1.57 Million - $1.9 Million	-63,384 Reduced 10.05%	567,345 $14.2 Million
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $1.57 Million - $1.9 Million	-63,384 Reduced 10.05%	567,345 $14.2 Million
Q1 2023 May 14, 2024	SELL	$25.95 - $36.95 $2.03 Million - $2.88 Million	-78,058 Reduced 11.01%	630,729 $17.6 Million
Q1 2023 May 11, 2023	SELL	$25.95 - $36.95 $2.03 Million - $2.88 Million	-78,058 Reduced 11.01%	630,729 $17.6 Million
Q4 2022 May 14, 2024	BUY	$24.79 - $30.86 $1.46 Million - $1.81 Million	58,717 Added 9.03%	708,787 $18.5 Million
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $1.46 Million - $1.81 Million	58,717 Added 9.03%	708,787 $18.5 Million
Q3 2022 May 14, 2024	BUY	$24.62 - $32.44 $3.16 Million - $4.16 Million	128,289 Added 24.59%	650,070 $16.9 Million
Q3 2022 Nov 10, 2022	BUY	$24.62 - $32.44 $3.16 Million - $4.16 Million	128,289 Added 24.59%	650,070 $16.9 Million
Q2 2022 May 14, 2024	BUY	$19.74 - $29.01 $1.66 Million - $2.43 Million	83,881 Added 19.16%	521,781 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $8 Million - $11.8 Million	405,458 Added 348.56%	521,781 $14.3 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $393,369 - $613,792	14,744 Added 14.51%	116,323 $3.1 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $1.39 Million - $1.8 Million	41,413 Added 68.83%	101,579 $4.08 Million
Q3 2021 Nov 10, 2021	BUY	$30.65 - $35.68 $1.84 Million - $2.15 Million	60,166 New	60,166 $1.97 Million

Others Institutions Holding XNCR

# of Institutions

205

Shares Held

81.9M

Call Options Held

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $892M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Xencor Inc Transaction History